Inspire Pharmaceuticals DEFA14A Additional proxy soliciting materials

Inspire Pharmaceuticals (ISPH) Inactive DEFA14AAdditional proxy soliciting materials

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant x

Filed by a Party other than the Registrant ¨

Check the appropriate box:

¨	Preliminary Proxy Statement

¨	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

¨	Definitive Proxy Statement

x	Definitive Additional Materials

¨	Soliciting Material Pursuant to §240.14a-12

Inspire Pharmaceuticals, Inc.

(Name of Registrant as Specified in its Charter)

Payment of Filing Fee (Check the appropriate box):

x	No fee required.

¨	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

(1)

Title of each class of securities to which transaction applies:

(2)

Aggregate number of securities to which transaction applies:

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

¨	Fee paid previously with preliminary materials:

¨	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

(1)

Amount Previously Paid:

(2)

Form, Schedule or Registration Statement No.:

(3)

Filing Party:

(4)

Date Filed:

*** Exercise YourRight to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 06, 2011

LOGO

INSPIRE PHARMACEUTICALS, INC.

Meeting Information

LOGO

Meeting Type:Annual Meeting

For holders as of:March 09, 2011

Date: May 06, 2011

Time: 8:00 AM EDT

Location: Inspire Pharmaceuticals

8081 Arco Corporate Drive

Suite 400

Raleigh, NC 27617

You are receiving this communication because you hold shares in the above named company.

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online atwww.proxyvote.com or easily request a paper copy (see reverse side).

We encourage you to access and review all of the important information contained in the proxy materials before voting.

See the reverse side of this notice to obtain proxy materials and voting instructions.

LOGO


				Before You Vote

How to Access the Proxy Materials


				How To Vote


				Please Choose One of the Following Voting Methods

				Vote In Person:If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions atwww.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
				Vote By Internet:To vote now by Internet, go towww.proxyvote.com. Have the information that is printed in the box marked by the arrow available and follow the instructions. Vote By Mail:You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.						Internal Use Only

Voting items

LOGO

The Board of Directors recommends that you

vote FOR the following:

Election of Directors

Nominees

Kip A. Frey

Kenneth B. Lee, Jr.

The Board of Directors recommends you vote FOR the following proposal (s):

Ratify the appointment of Pricewaterhouse Coopers LLP by the Audit Committee of our Board of Directors as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2011.

An advisory vote regarding the compensation of our named executive officers (“Say on Pay”).

The Board of Directors recommends you vote 1 YEAR on the following proposal:

LOGO

An advisory vote regarding the frequency of stockholder voting on the compensation of our named executive officers.

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.


		Reserved for Broadridge Internal Control Information


		Voting Instructions

Proxy Materials Available to VIEW or RECEIVE:

1. Notice & Proxy Statement        2. Annual Report/10K Wrap

How to View Online:

Have the information that is printed in the box marked by the arrow (located on the following page) and visit:www.proxyvote.com.

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

                                 1)BY INTERNET:         www.proxyvote.com
                                 2)BY TELEPHONE:     1-800-579-1639
                                 3)BY E-MAIL*:             sendmaterial@proxyvote.com

  *  If requesting materials by e-mail, please send a blank e-mail with the information that is printed
   in the box marked by the arrow (located on the following page) in the subject line.

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 24, 2011 to facilitate timely delivery.